Company Filing History:
Years Active: 2007
Title: Georg Lauer: Innovator in Hepatitis C Research
Introduction
Georg Lauer is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines and immunotherapies for hepatitis C virus (HCV).
Latest Patents
Lauer holds a patent for his invention titled "Epitopes of hepatitis C virus." This invention provides compositions containing HCV epitopes that are recognized by cytotoxic T lymphocytes. The polypeptides developed from this invention are utilized in prophylactic vaccines, immunotherapies, and assays to monitor the progress or success of immune interventions. The compositions are optimized to elicit an immune response in a genetically diverse population of individuals. He has 1 patent to his name.
Career Highlights
Georg Lauer is associated with The General Hospital Corporation, where he continues to advance research in the field of hepatitis C. His work has been instrumental in understanding the immune response to HCV and developing effective therapeutic strategies.
Collaborations
Lauer has collaborated with notable colleagues, including Kei Ouchi and Bruce D Walker, who share his commitment to advancing medical research and improving patient outcomes.
Conclusion
Georg Lauer's innovative work in hepatitis C research exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for new therapeutic approaches to combat this challenging virus.